- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03723265
Personalized CRT - PSR
May 19, 2022 updated by: Medtronic
Personalized CRT - Product Surveillance Registry (PSR)
The purpose of this study is to evaluate the cardiac resynchronization therapy (CRT) response in a real-world patient population and evaluate options to address non-response and patient management.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The Personalized CRT study is a multi-center, single arm, prospective observational study.
The purpose of the study is to better understand and characterize heart failure (HF) patient management by characterizing the use and clinical benefit of Medtronic market-released features/tools within the HF Patient Management portfolio.
Study Type
Observational
Enrollment (Actual)
1517
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leuven, Belgium
-
Yvoir, Belgium
-
-
-
-
-
Calgary, Canada
-
Kingston, Canada
-
Montreal, Canada
-
Québec, Canada
-
-
-
-
-
Clermont-Ferrand, France
-
La Rochelle, France
-
Montpellier, France
-
Nantes, France
-
Pringy, France
-
-
-
-
-
Aachen, Germany
-
Essen, Germany
-
Hannover, Germany
-
Homburg, Germany
-
Köln, Germany
-
Tübingen, Germany
-
Ulm, Germany
-
-
-
-
-
Milano, Italy
-
Reggio Emilia, Italy
-
-
-
-
-
Seoul, Korea, Republic of
-
-
-
-
-
Kuala Lumpur, Malaysia
-
-
-
-
-
Eindhoven, Netherlands
-
Maastricht, Netherlands
-
Nieuwegein, Netherlands
-
Rotterdam, Netherlands
-
-
-
-
-
Belgrade, Serbia
-
-
-
-
-
A Coruña, Spain
-
Palma de Mallorca, Spain
-
-
-
-
-
Skövde, Sweden
-
-
-
-
-
Birmingham, United Kingdom
-
Liverpool, United Kingdom
-
Manchester, United Kingdom
-
Middlesbrough, United Kingdom
-
-
-
-
Alabama
-
Birmingham, Alabama, United States
-
-
Alaska
-
Anchorage, Alaska, United States
-
-
Arizona
-
Gilbert, Arizona, United States
-
-
Arkansas
-
Jonesboro, Arkansas, United States
-
Little Rock, Arkansas, United States
-
-
California
-
Bakersfield, California, United States
-
Chula Vista, California, United States
-
Palm Springs, California, United States
-
Rancho Mirage, California, United States
-
Redwood City, California, United States
-
Salinas, California, United States
-
San Diego, California, United States
-
Stanford, California, United States
-
Torrance, California, United States
-
Van Nuys, California, United States
-
-
Colorado
-
Denver, Colorado, United States
-
Lakewood, Colorado, United States
-
-
Connecticut
-
New Haven, Connecticut, United States
-
-
District of Columbia
-
Washington, District of Columbia, United States
-
-
Florida
-
Bradenton, Florida, United States
-
Clearwater, Florida, United States
-
Jacksonville, Florida, United States
-
Safety Harbor, Florida, United States
-
-
Georgia
-
Albany, Georgia, United States
-
Marietta, Georgia, United States
-
-
Indiana
-
Evansville, Indiana, United States
-
Indianapolis, Indiana, United States
-
-
Iowa
-
West Des Moines, Iowa, United States
-
-
Kansas
-
Kansas City, Kansas, United States
-
-
Kentucky
-
Edgewood, Kentucky, United States
-
Louisville, Kentucky, United States
-
-
Louisiana
-
Baton Rouge, Louisiana, United States
-
New Orleans, Louisiana, United States
-
-
Maryland
-
Baltimore, Maryland, United States
-
Clinton, Maryland, United States
-
Salisbury, Maryland, United States
-
Silver Spring, Maryland, United States
-
Takoma Park, Maryland, United States
-
-
Massachusetts
-
Boston, Massachusetts, United States
-
Worcester, Massachusetts, United States
-
-
Michigan
-
Lansing, Michigan, United States
-
Marquette, Michigan, United States
-
Ypsilanti, Michigan, United States
-
-
Minnesota
-
Minneapolis, Minnesota, United States
-
Robbinsdale, Minnesota, United States
-
Rochester, Minnesota, United States
-
Saint Louis Park, Minnesota, United States
-
-
Missouri
-
Columbia, Missouri, United States
-
Kansas City, Missouri, United States
-
Saint Louis, Missouri, United States
-
-
Nevada
-
Las Vegas, Nevada, United States
-
-
New Jersey
-
Morristown, New Jersey, United States
-
Ocean Township, New Jersey, United States
-
-
New Mexico
-
Albuquerque, New Mexico, United States
-
-
New York
-
Garden City, New York, United States
-
Huntington, New York, United States
-
Manhasset, New York, United States
-
New York, New York, United States
-
Poughkeepsie, New York, United States
-
Utica, New York, United States
-
-
North Carolina
-
Durham, North Carolina, United States
-
Raleigh, North Carolina, United States
-
-
Ohio
-
Akron, Ohio, United States
-
Cincinnati, Ohio, United States
-
Cleveland, Ohio, United States
-
Toledo, Ohio, United States
-
-
Oregon
-
Portland, Oregon, United States
-
-
Pennsylvania
-
Allentown, Pennsylvania, United States
-
Bethlehem, Pennsylvania, United States
-
Danville, Pennsylvania, United States
-
Erie, Pennsylvania, United States
-
Lancaster, Pennsylvania, United States
-
Philadelphia, Pennsylvania, United States
-
Pittsburgh, Pennsylvania, United States
-
Wilkes-Barre, Pennsylvania, United States
-
-
South Carolina
-
Columbia, South Carolina, United States
-
-
Tennessee
-
Germantown, Tennessee, United States
-
Kingsport, Tennessee, United States
-
Nashville, Tennessee, United States
-
-
Texas
-
Austin, Texas, United States
-
Dallas, Texas, United States
-
Fort Worth, Texas, United States
-
Plano, Texas, United States
-
The Woodlands, Texas, United States
-
-
Vermont
-
Burlington, Vermont, United States
-
-
Washington
-
Spokane, Washington, United States
-
-
Wisconsin
-
Madison, Wisconsin, United States
-
Milwaukee, Wisconsin, United States
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The study population includes patients that are or will be implanted with an eligible CRT system.
Description
Inclusion Criteria:
- Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
- Patient has or is intended to receive or be treated with an eligible CRT device
- Patient within 30 days of therapy received at the time of their initial PSR platform enrollment
Exclusion Criteria:
- Patient who is, or is expected to be inaccessible for follow-up
- Patient with exclusion criteria required by local law
- Patient is currently enrolled in or plans to enroll in any concurrent drug and/ or device study that may confound results
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CRT Response
Time Frame: Every 3-9 months
|
A Clinical Composite Score (CCS) endpoint will be used to assess a change in CRT response for all patients from baseline to follow-up visits.
|
Every 3-9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treatments for CRT non-response
Time Frame: Every 3-9 months
|
Summary statistics will be obtained to describe the distribution of different treatments (or no treatment) the patient receives.
|
Every 3-9 months
|
|
Treatment effects for different CRT features in the CRT non-responder population
Time Frame: Every 3-9 months
|
A Clinical Composite Score (CCS) endpoint will be used to assess a change in CRT response.
|
Every 3-9 months
|
|
Patient outcome post initial CRT implant
Time Frame: Every 3-9 months
|
Patient outcome will be measured as the patient first occurrence of HF related hospitalization or death.
|
Every 3-9 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2012
Primary Completion (Actual)
April 28, 2022
Study Completion (Actual)
April 28, 2022
Study Registration Dates
First Submitted
October 15, 2018
First Submitted That Met QC Criteria
October 26, 2018
First Posted (Actual)
October 29, 2018
Study Record Updates
Last Update Posted (Actual)
May 20, 2022
Last Update Submitted That Met QC Criteria
May 19, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Personalized CRT
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.